Cargando…

Tiempo en rango terapéutico e incidencia de complicaciones por warfarina en una cohorte retrospectiva de 20 años

OBJECTIVE: To characterize the time in therapeutic range (TTR) and estimate the incidence rate of complications (PTIRc) in adults with warfarin protocol. DESIGN: Retrospective cohort based on medical records of patients older than 18 years, between 1996 and 2016 and followed for at least three month...

Descripción completa

Detalles Bibliográficos
Autores principales: Falcone, Marinela, Martín Mateo, Miguel, Romero-Sandoval, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249676/
https://www.ncbi.nlm.nih.gov/pubmed/35759941
http://dx.doi.org/10.1016/j.aprim.2022.102410
_version_ 1784739639296262144
author Falcone, Marinela
Martín Mateo, Miguel
Romero-Sandoval, Natalia
author_facet Falcone, Marinela
Martín Mateo, Miguel
Romero-Sandoval, Natalia
author_sort Falcone, Marinela
collection PubMed
description OBJECTIVE: To characterize the time in therapeutic range (TTR) and estimate the incidence rate of complications (PTIRc) in adults with warfarin protocol. DESIGN: Retrospective cohort based on medical records of patients older than 18 years, between 1996 and 2016 and followed for at least three months. SITE: Hematology unit of a Venezuelan specialized cardiovascular center. PARTICIPANTS: Electronic health record. MAIN MEASUREMENTS: TTR and PTIRc. The variables were sex, functional illiteracy, occupation, International Normalized Ratio (INR) and follow-up time, which were analyzed with TTR and PTIRc using binomial logistic and Poisson regression models, respectively. RESULTS: 2,770 patients were followed up for a total of 1,201,380 days, 42.3% had a TTR < 65% and 3.5% had INR 2.5-3.5. 61.8% had complications. PTIRc was 6.84/100 person-months (95% CI: 6.56-7.15). TTR < 65% showed significant adjusted OR with functional illiteracy and INR 2.5-3.5, while for higher PTIRc a significant RR was found in the two factors mentioned, shorter follow-up time, TTR < 65% and in women. CONCLUSIONS: Despite new anticoagulant treatments, warfarin is useful. As follow-up time increased, control was better and the rate of occurrence of complications decreased; however, the conditions that showed lower TTR and higher rate of occurrence of complications require a thorough review of follow-up especially in patients with functional illiteracy.
format Online
Article
Text
id pubmed-9249676
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92496762022-07-03 Tiempo en rango terapéutico e incidencia de complicaciones por warfarina en una cohorte retrospectiva de 20 años Falcone, Marinela Martín Mateo, Miguel Romero-Sandoval, Natalia Aten Primaria Original OBJECTIVE: To characterize the time in therapeutic range (TTR) and estimate the incidence rate of complications (PTIRc) in adults with warfarin protocol. DESIGN: Retrospective cohort based on medical records of patients older than 18 years, between 1996 and 2016 and followed for at least three months. SITE: Hematology unit of a Venezuelan specialized cardiovascular center. PARTICIPANTS: Electronic health record. MAIN MEASUREMENTS: TTR and PTIRc. The variables were sex, functional illiteracy, occupation, International Normalized Ratio (INR) and follow-up time, which were analyzed with TTR and PTIRc using binomial logistic and Poisson regression models, respectively. RESULTS: 2,770 patients were followed up for a total of 1,201,380 days, 42.3% had a TTR < 65% and 3.5% had INR 2.5-3.5. 61.8% had complications. PTIRc was 6.84/100 person-months (95% CI: 6.56-7.15). TTR < 65% showed significant adjusted OR with functional illiteracy and INR 2.5-3.5, while for higher PTIRc a significant RR was found in the two factors mentioned, shorter follow-up time, TTR < 65% and in women. CONCLUSIONS: Despite new anticoagulant treatments, warfarin is useful. As follow-up time increased, control was better and the rate of occurrence of complications decreased; however, the conditions that showed lower TTR and higher rate of occurrence of complications require a thorough review of follow-up especially in patients with functional illiteracy. Elsevier 2022-08 2022-06-24 /pmc/articles/PMC9249676/ /pubmed/35759941 http://dx.doi.org/10.1016/j.aprim.2022.102410 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original
Falcone, Marinela
Martín Mateo, Miguel
Romero-Sandoval, Natalia
Tiempo en rango terapéutico e incidencia de complicaciones por warfarina en una cohorte retrospectiva de 20 años
title Tiempo en rango terapéutico e incidencia de complicaciones por warfarina en una cohorte retrospectiva de 20 años
title_full Tiempo en rango terapéutico e incidencia de complicaciones por warfarina en una cohorte retrospectiva de 20 años
title_fullStr Tiempo en rango terapéutico e incidencia de complicaciones por warfarina en una cohorte retrospectiva de 20 años
title_full_unstemmed Tiempo en rango terapéutico e incidencia de complicaciones por warfarina en una cohorte retrospectiva de 20 años
title_short Tiempo en rango terapéutico e incidencia de complicaciones por warfarina en una cohorte retrospectiva de 20 años
title_sort tiempo en rango terapéutico e incidencia de complicaciones por warfarina en una cohorte retrospectiva de 20 años
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249676/
https://www.ncbi.nlm.nih.gov/pubmed/35759941
http://dx.doi.org/10.1016/j.aprim.2022.102410
work_keys_str_mv AT falconemarinela tiempoenrangoterapeuticoeincidenciadecomplicacionesporwarfarinaenunacohorteretrospectivade20anos
AT martinmateomiguel tiempoenrangoterapeuticoeincidenciadecomplicacionesporwarfarinaenunacohorteretrospectivade20anos
AT romerosandovalnatalia tiempoenrangoterapeuticoeincidenciadecomplicacionesporwarfarinaenunacohorteretrospectivade20anos
AT tiempoenrangoterapeuticoeincidenciadecomplicacionesporwarfarinaenunacohorteretrospectivade20anos